期刊文献+

抗表皮生长因子受体单抗联合X线照射对人鼻咽癌细胞株CNE-2的作用 被引量:2

Effect of combined anti-EGFR and X-ray irradiation on human nasopharyngeal carcinoma cell line CNE-2
下载PDF
导出
摘要 目的观察抗表皮生长因子受体(epidermal growth factor receptor,EGFR)尼妥珠单抗(h-R3)、西妥昔单抗(C225)分别联合X线照射对人鼻咽癌细胞株CNE-2的作用。方法采用流式细胞仪测定CNE-2细胞表面EGFR表达情况;采用PCRDNA测序技术筛选K-ras野生型CNE-2细胞;采用MTS法检测细胞增殖情况;采用克隆形成实验拟合细胞存活曲线;通过流式细胞仪分析细胞周期分布及细胞凋亡变化。结果在调节CNE-2细胞克隆存活及凋亡方面,C225联合X线照射组的作用优于h-R3联合X线照射组(P<0.05);在细胞增殖及细胞周期方面,h-R3联合X线照射组与C225联合X线照射组之间差异无明显统计学意义(P>0.05)。结论 h-R3与C225均能提高X线照射对CNE-2细胞的抗肿瘤作用,C225对该细胞株杀伤作用略优于h-R3。 Objective To study the effect of anti-EGFR mAbs, nimotuzumab (h-R3) and cetuximab (C225), in combination with X-ray irradiation on human nasopharyngeal carcinoma cell line CNE-2. Methods Expression of surface EGFR in CNE-2 cells was detected by flow cytometry (FCM). Wild K-ras CNE-2 cells were detected by PCR-DNA sequencing. Proliferation of CNE-2 cells was assayed by MTS. Cell survival curves were plotted by clone formation experiment. Cell-cycle distribution and apoptosis were analyzed by FCM. Results The effect of combined C225 and X-ray irradiation was better than that of combined h-R3 and X-ray irradiation on the survival and apoptosis of CNE-2 cells (P 〈 0.05). However, no significant difference was observed in their effect on cell cycle distribution and proliferation (P 〉 0.05). Conclusion Both h-R3 and C225 can enhance the anti-tumor effect of X-ray irradiation on CNE-2 cells. The effect of C225 is better than that of h-R3 on CNE-2 cells.
出处 《解放军医学院学报》 CAS 2014年第4期360-364,共5页 Academic Journal of Chinese PLA Medical School
基金 解放军总医院临床科研扶持基金(2012FC-TSYS-1009)
关键词 表皮生长因子受体 西妥昔单抗 尼妥珠单抗 鼻咽癌 放射敏感性 epidermal growth factor receptor cetuximab nimotuzumab nasopharyngeal carcinoma radiosensitivity
  • 相关文献

参考文献22

  • 1王树森,管忠震,向燕群,汪波,林桐榆,姜文奇,张力,张惠忠,侯景辉.鼻咽癌组织中EGFR和p-ERK蛋白表达的检测及意义[J].中华肿瘤杂志,2006,28(1):28-31. 被引量:46
  • 2Harari PM,Huang SM. Modulation of molecular targets to enhance radiation[J].Clinical Cancer Research,2000,(02):323-325.
  • 3Mendelsohn J. Targeting the epidermal growth factor receptor for cancer therapy[J].Journal of Clinical Oncology,2002,(18 Suppl):1S-13S.
  • 4Milas L,Fan Z,Andratschke NH. Epidermal growth factor receptor and tumor response to radiation:in vivo preclinical studies[J].International Journal of Radiation Oncology Biology Physics,2004,(03):966-971.
  • 5Pryor DI,Porceddu SV,Burmeister BH. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck Cancer[J].Radiotherapy and Oncology,2009,(02):172-176.
  • 6Crombet T,Osorio M,Cruz T. Use of the humanized antiepidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck Cancer patients[J].Journal of Clinical Oncology,2004,(09):1646-1654.
  • 7Akashi Y,Okamoto I,Iwasa T. Enhancement of the antitumor activity of ionising radiation by nimotuzumab,a humanised monoclonal antibody to the epidermal growth factor receptor,in nonsmall cell lung Cancer cell lines of differing epidermal growth factor receptor status[J].British Journal of Cancer,2008,(04):749-755.
  • 8Allan DG. Nimotuzumab:evidence of clinical benefit without rash[J].Oncologist(the)t,2005,(09):760-761.
  • 9Zhao L,He LR,Xi M. Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3[J].Journal of Translational Medicine,2012.249.
  • 10Jing Z,Gong L,Xie CY. Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab[J].Radiotherapy and Oncology,2009,(03):468-473.

二级参考文献12

  • 1Brabender J,Danenberg KD,Metzger R,et al.Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival.Clin Cancer Res,2001,7:1850-1855.
  • 2Fromowitz FB,Viola MV,Chao S,et al.Ras p21 expression in the progression of breast cancer.Hum Pathol,1987,18:1268-1275.
  • 3Salomon DS,Brandt R,Ciardiello F,et al.Epidermal growth factorrelated peptides and their receptors in human malignancies.Crit Rev Oncol Hematol,1995,19:183-232.
  • 4Fujiii M,Yamashita T,Fshiguro R,et al.Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma.Auris Nasus Larynx,2002,29:175-181.
  • 5Putti TC,To KF,Hsu HC,et al.Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression:a multicentre immunohistochemical study in the AsiaPacific region.Histopathology,2002,41:144-151.
  • 6Yang HJ,Cho YJ,Kim HS,et al.Association of p53 and bcl-2expression with Epstein-Barr virus infection in the cancers of the head and neck.Head Neck,2001,23:629-636.
  • 7Ma B,Poon T,To KF,et al.Prognostic significance of tumor angiogenesis,KI67,p53 oncoprotein,epidermal growth factor receptor and HER2 receptor protein expressiosn in undifferentiated nasopharyngeal carcinoma:a prospective study.Head Neck,2003,25:864-872.
  • 8Sheen TS,Huang YZ,Chang YL,et al.Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma.Jpn J Cancer,1999,90:1285-1292.
  • 9Leong JL,Lob KS,Putti TC,et al.Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx.Larygscope,2004,114:153-157.
  • 10Roychowdhury DF,Tseng A,Fu KK,et al.New prognostic factors in nasopharyngeal carcinoma.Cancer,1996,77:1419-1426.

共引文献45

同被引文献28

  • 1BESSMAN N J,FREED D M,LEMMON M A.Putting together structures of epidermal growth factor receptors[J].Curr Opin Struct Biol,2014,29:95-101.
  • 2ZHANG P1 WU S K,WANG Y,et al.p53,MDM2,eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinic pathological characteristics and prognosis:a retrospec- tive study[J].Oncol Lett,2015,9(1);113-118.
  • 3PAN J,TANG T,XU L,et al.Prognostic significance of expres- sion of cyclooxygenase-2,vascular endothelial growth factor,and epidermal growth factor receptor in nasopharyngeal carcinoma[J].Head Neck,2013,35(9):1238-1247.
  • 4MA X,HUANG J,WU X,et al.Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyn- geal carcinoma:a meta-analysis[J].Cancer Biomark.2014;14(4):267-277.
  • 5SUN W,LONG G,WANG J,et al.Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma;a meta-analy- sis.[J].Head Neck.2014,36(10):1508-1516.
  • 6GU W G,HUANG Y,YUAN Z Y,et al.ZD1839 and cisplatin alone or in combination for treatment of a nasopharyngeal carcino- ma cell line and Xenograftsf J].Asian Pac J Cancer Prev,2013,14(3):1787-1790.
  • 7UU Y,LI Z,WU L,et al.MiRNA-125a-5p;a regulator and predictor of gefitinib' s effect on nasopharyngeal carcinoma[J].Cancer Cell Int,2014,14(1):24.
  • 8马幕.吉非替尼通过EGFR/AKT/β-catenin途径抑制鼻咽癌肿瘤干细胞[D].广州:南方医科大学,2012.
  • 9CHEN S L,MA B B.Novel systemic therapeutic for nasopharyn- geal carcinoma[J].Expert Opin Ther Target.2012,16(Suppl I):S63-S68.
  • 10WU R ft,XIAO Z Y,WANG C,et al.Phase II clinical trial of h- R3 combined with radiotherapy in locally advanced nasopharyngeal carcinoma[J].J BUON,2014,19(4):930-936.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部